Edwards Lifesciences has obtained European regulatory approval for its SAPIEN M3 system, making it the world’s first transcatheter mitral valve replacement therapy delivered via a transfemoral approach for treating mitral regurgitation.
Womed has launched its pioneering medical device designed to prevent intrauterine adhesions (IUA) across 14 European countries through new distribution partnerships with Kebomed Europe and Saesco Medical.
Philips has announced that its Radiology Operations Command Center Console has received EU Medical Device Regulation (MDR) certification for remote scanning capability, enabling expert radiologists to remotely control scans and assist technologists in real-time across multiple locations in Europe.
Baxter International Inc. has announced the European launch of its Hemopatch Sealing Hemostat with room temperature storage capability, eliminating the need for refrigeration and enabling immediate accessibility in operating theatres.
The European Medicines Agency has qualified the first artificial intelligence-based tool designed to evaluate liver biopsies in patients with metabolic dysfunction-associated steatohepatitis (MASH). The system, called AIM-NASH, helps pathologists assess disease severity and reduce variability in histological scoring, with the aim of accelerating drug development for this increasingly common liver condition.
Beckman Coulter Life Sciences has launched a ground-breaking Next-Generation Basophil Activation Test (BAT) that could transform food allergy research by eliminating the need for potentially dangerous allergen exposure.
Fujifilm Healthcare Europe has announced the European release of their EG-740UT interventional ultrasonic endoscope. The device incorporates miniaturised single crystal transducer technology, enhancing diagnostic and therapeutic capabilities for endoscopic ultrasound procedures through improved visibility, manoeuvrability and image quality.
Yourgene Health has introduced IONA Care+, an enhanced non-invasive prenatal testing (NIPT) service that expands screening capabilities to include microdeletion syndromes alongside chromosomal abnormalities, offering expectant parents comprehensive genetic risk assessment from as early as 10 weeks’ gestation.
Vitestro, a Netherlands-based medical robotics company, has launched Aletta™, the world’s first Autonomous Robotic Phlebotomy Device™ (ARPD™). This CE-marked technology utilises AI-powered Doppler ultrasound imaging to identify veins and employs robotic-controlled needle insertion for blood collection, promising enhanced precision and consistency compared to traditional manual methods.
Vetter Pharma has unveiled its V-OVS® next syringe closure system, evolving their proprietary technology based on real-world clinical feedback. The updated design promises enhanced functionality, improved handling, and intuitive opening mechanisms while maintaining stringent product integrity standards for sterile injectables.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.